---
schema_version: "secwatch.filing_event.v1"
accession: "0000313143-26-000003"
form_type: "8-K"
ticker: "HAE"
cik: "0000313143"
company_name: "HAEMONETICS CORP"
filed_at: "2026-01-09T23:59:59+00:00"
generated_at: "2026-05-16T11:07:31.456618+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Haemonetics acquires Vivasure Medical for up to €185M; upfront €100M plus €85M earn-out

## Summary
- Acquired all equity of Vivasure Medical, a Galway, Ireland-based developer of percutaneous vessel closure technology.
- Upfront consideration of €100M, net €52M after deducting prior investments and loans.
- Up to €85M in contingent consideration tied to sales growth and other milestones.
- Transaction funded with available cash on hand.

## SEC filing metadata
- accession: 0000313143-26-000003
- form_type: 8-K
- ticker: HAE
- cik: 0000313143
- company_name: HAEMONETICS CORP
- filed_at: 2026-01-09T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/313143/000031314326000003/0000313143-26-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/313143/000031314326000003/hae-20260109.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000313143-26-000003
- JSON: https://secwatch.observer/filing/0000313143-26-000003.json
- Plain text: https://secwatch.observer/filing/0000313143-26-000003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.